Nanjing Hicin Pharmaceutical Co Ltd (300584) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.007x

Based on the latest financial reports, Nanjing Hicin Pharmaceutical Co Ltd (300584) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.15 Million ≈ $-1.05 Million USD) by net assets (CN¥1.07 Billion ≈ $157.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Nanjing Hicin Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

Nanjing Hicin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Nanjing Hicin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Nanjing Hicin Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Nanjing Hicin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanjing Hicin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Santacruz Silver Mining Ltd. V:SCZ	0.042x
Jiangsu Transimage Technology Co Ltd SHE:002866	0.011x
Ranhill Holdings Ltd KLSE:5272	0.153x
Attacq JSE:ATT	0.030x
Cowealth Medical China Co.Ltd. SHG:603122	N/A
Zhejiang Starry Pharm Co Ltd SHG:603520	0.004x
Talkspace Inc NASDAQ:TALK	0.044x
PNE AG XETRA:PNE3	-0.170x

Annual Cash Flow Conversion Efficiency for Nanjing Hicin Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 300584 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.10 Billion ≈ $160.94 Million	CN¥78.09 Million ≈ $11.43 Million	0.071x	+22.93%
2024-12-31	CN¥1.04 Billion ≈ $151.92 Million	CN¥59.96 Million ≈ $8.77 Million	0.058x	+138.31%
2023-12-31	CN¥987.50 Million ≈ $144.50 Million	CN¥23.93 Million ≈ $3.50 Million	0.024x	+495.88%
2022-12-31	CN¥950.57 Million ≈ $139.10 Million	CN¥-5.82 Million ≈ $-851.55K	-0.006x	-109.69%
2021-12-31	CN¥948.48 Million ≈ $138.79 Million	CN¥59.94 Million ≈ $8.77 Million	0.063x	-41.53%
2020-12-31	CN¥678.97 Million ≈ $99.35 Million	CN¥73.39 Million ≈ $10.74 Million	0.108x	-27.33%
2019-12-31	CN¥653.98 Million ≈ $95.70 Million	CN¥97.28 Million ≈ $14.23 Million	0.149x	+11.91%
2018-12-31	CN¥580.93 Million ≈ $85.01 Million	CN¥77.21 Million ≈ $11.30 Million	0.133x	+47.79%
2017-12-31	CN¥517.68 Million ≈ $75.75 Million	CN¥46.56 Million ≈ $6.81 Million	0.090x	-34.20%
2016-12-31	CN¥276.11 Million ≈ $40.40 Million	CN¥37.74 Million ≈ $5.52 Million	0.137x	-40.39%
2015-12-31	CN¥235.08 Million ≈ $34.40 Million	CN¥53.90 Million ≈ $7.89 Million	0.229x	+88.91%
2014-12-31	CN¥200.15 Million ≈ $29.29 Million	CN¥24.29 Million ≈ $3.55 Million	0.121x	-55.41%
2013-12-31	CN¥165.93 Million ≈ $24.28 Million	CN¥45.16 Million ≈ $6.61 Million	0.272x	-6.87%
2012-12-31	CN¥132.65 Million ≈ $19.41 Million	CN¥38.77 Million ≈ $5.67 Million	0.292x	--

About Nanjing Hicin Pharmaceutical Co Ltd

SHE:300584 China Drug Manufacturers - Specialty & Generic

Market Cap

$650.06 Million

CN¥4.44 Billion CNY

Market Cap Rank

#11016 Global

#3069 in China

Share Price

CN¥37.02

Change (1 day)

-2.32%

52-Week Range

CN¥30.27 - CN¥77.88

All Time High

CN¥83.16